Why isn’t cancer just a footnote to a chapter of history, instead of an unfolding chapter of HIS story."
lamented Markley Masraff Berg, when she learned her dad Tony Masraff was diagnosed with prostate cancer.
Tony’s Prostate Cancer Research Foundation (TPCR) is a 501 (c)(3) non-profit organization, established in 2002 by Houstonian Tony Masraff.
With a mission to raise awareness and fund research leading to the development of a non-invasive cure of prostate cancer.
To this end, TPCR beneficiaries include renowned medical institutions and U.S and Canadian bio-technology researchers in the area of essential research leading to a more profound understanding of the disease, its progression, cell immune responses and host susceptibility to rapid cell mutation.
The Masraff family has demonstrated an abiding commitment to collaborate with the private philanthropic sector to raise funds to support biomedical research, FDA required safety testing of the GLIPR1 and the GLIPR1 GNP development for clinical trials.
WHAT IS GLIPR1?
Dr. Christopher Logothetis (Chairman Genitourinary Medicine MDA) declared that the GLIPR1 therapy “…will forever change the way the world views all cancers.”
In layman’s terms, the GLIPR1 is the natural cancer-suppressing protein which is present in our healthy organs. The GLIPR1 therapy has proven to be effective in a lab setting in protecting against the new growth of cancer cells in exposed animals, in destroying existing prostate cancer tumors, all the while showing no measurable side effects.
To quote from the Research Results Section of the October 2017 Progress Report by Timothy Thompson, PhD regarding the unique properties of the GLIPR 1, “It not only kills cancer cells, but also suppresses angiogenic activities and stimulates T-cell mediated response against cancer cells…”
According to Research Scientist Timothy Thompson, PhD “… what we are doing with the GLIPR1 is a paradigm shift in the medical community which couldn’t have been possible without Tony Masraff’s support and involvement over the years.”